1. Home
  2. VCYT

VCYT

Veracyte Inc.

Logo Veracyte Inc.

Health Care

Medical Specialities

Nasdaq

as 04-17-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

Founded: N/A Country:
United States
United States
Employees: 815 City: SOUTH SAN FRANCISCO
Market Cap: 1.4B IPO Year: 2013
Target Price: $29.00 AVG Volume (30 days): 635.9K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.02 EPS Growth: N/A
52 Week Low/High: $19.52 - $30.52 Next Earning Date: 05-02-2024
Revenue: $361,051,000 Revenue Growth: 21.76%
Revenue Growth (this year): 12.39% Revenue Growth (next year): 11.44%

Share on Social Networks: